SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," said insulin4all advocate Allison Bailey. (Photo: 2C2KPhotography/flickr/cc)
#CaravanToCanada: Facing Insulin Prices 10X Higher in US, Group Heads Across Border
"We should not have to drive five hours to Canada to be able to afford #insulin!"
May 08, 2019
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.